News of Note—Lasker awards, Targovax and FluMist

newspaper
In this week's news of note, two HPV vaccine researchers won Lasker awards.

> Officials are still trying to pinpoint why efficacy for AstraZeneca's FluMist took a dive in the U.S. CIDRAP article

> National Cancer Institute researchers Douglas Lowy and John Schiller won Lasker awards for their HPV vaccine work. Release

> Targovax started recruitment for an early study of its ONCOS-102 in combo with AstraZeneca's Imfinzi in patients with advanced peritoneal malignancies. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.
Read more on